EGFR immunolabeling pattern may discriminate low-grade gliomas from gliosis

Journal of Neuro-Oncology

Volumn 102, Issue 2, 2011, Pages 171-178

  Burel Vandenbos, Fanny ^a,c   Benchetrit, Maxime ^a   Miquel, Catherine ^b   Fontaine, Denys ^a   Auvergne, Romane ^a   Lebrun Frenay, Christine ^a   Cardot Leccia, Nathalie ^a   Michiels, Jean François ^a   Paquis Flucklinger, Veronique ^a   Virolle, Thierry ^c  

^a UNIVERSITY HOSPITAL OF NICE   (France)

^b CENTRE HOSPITALIER SAINTE ANNE   (France)

^c UNIVERSITÉ CÔTE D'AZUR   (France)

Author keywords

EGFR; Gliosis; Immunohistochemistry; Low grade gliomas

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY KI 67; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2; PROTEIN P53;

ANTIBODY LABELING; ARTICLE; ASTROCYTOMA; CANCER GRADING; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; GLIOMA; GLIOSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOLECULAR PATHOLOGY; OLIGODENDROGLIOMA; PROTEIN EXPRESSION;

ADENOCARCINOMA; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BRAIN NEOPLASMS; CARCINOMA, SQUAMOUS CELL; GLIOMA; GLIOSIS; HUMANS; IMMUNOENZYME TECHNIQUES; MELANOMA; NERVE TISSUE PROTEINS; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITIN-PROTEIN LIGASES;

EID: 79953697686     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-010-0308-4     Document Type: Article

References (37)

1. Yano S, Kondo K, Yamaguchi M, Richmond G, Hutchison M, Wakeling A, Averbuch S, Wadsworth P (2003) Distribution and function of EGFR in human tissue and the effect of EGFR tyrosine kinase inhibition. Anticancer Res 23:3639-3650 (Pubitemid 37474306)
2. Wong RW, Guillaud L (2004) The role of epidermal growth factor and its receptors in mammalian CNS. Cytokine Growth Factor Rev 15:147-156 (Pubitemid 38521250)
3. Nieto-Sampedro M, Gomez-Pinilla F, Knauer DJ, Broderick JT (1988) Epidermal growth factor receptor immunoreactivity in rat brain astrocytes. Response to injury. Neurosci Lett 91:276-282
4. Junier MP, Coulpier M, Le Forestier N, Cadusseau J, Suzuki F, Peschanski M, Dreyfus PA (1994) Transforming growth factor alpha (TGF alpha) expression in degenerating motoneurons of the murine mutant wobbler: a neuronal signal for astrogliosis? J Neurosci 14:4206-4216 (Pubitemid 24200544)
5. Ferrer I, Alcantara S, Ballabriga J, Olive M, Blanco R, Rivera R, Carmona M, Berruezo M, Pitarch S, Planas AM (1996) Transforming growth factor-alpha (TGF-alpha) and epidermal growth factor-receptor (EGF-R) immunoreactivity in normal and pathologic brain. Prog Neurobiol 49:99-123 (Pubitemid 26253264)
6. Planas AM, Justicia C, Soriano MA, Ferrer I (1998) Epidermal growth factor receptor in proliferating reactive glia following transient focal ischemia in the rat brain. Glia 23:120-129 (Pubitemid 28229085)
7. Rabchevsky AG, Weinitz JM, Coulpier M, Fages C, Tinel M, Junier MP (1998) A role for transforming growth factor alpha as an inducer of astrogliosis. J Neurosci 18:10541-10552 (Pubitemid 29016573)
8. Grandis JR, Sok JC (2004) Signaling through the epidermal growth factor receptor during the development of malignancy. Pharmacol Ther 102:37-46 (Pubitemid 38429984)
9. Etienne MC, Formento JL, Lebrun-Frenay C, Gioanni J, Chatel M, Paquis P, Bernard C, Courdi A, Bensadoun RJ, Pignol JP, Francoual M, Grellier P, Frenay M, Milano G (1998) Epidermal growth factor receptor and labeling index are independent prognostic factors in glial tumor outcome. Clin Cancer Res 4: 2383-2390 (Pubitemid 28477903)
10. Feldkamp MM, Lala P, Lau N, Roncari L, Guha A (1999) Expression of activated epidermal growth factor receptors, Rasguanosine triphosphate, and mitogen-activated protein kinase in human glioblastoma multiforme specimens. Neurosurgery 45: 1442-1453
11. Korshunov A, Golanov A, Sycheva R, Pronin I (1999) Prognostic value of tumour associated antigen immunoreactivity and apoptosis in cerebral glioblastomas: an analysis of 168 cases. J Clin Pathol 52:574-580 (Pubitemid 29371901)
12. Chakravarti A, Delaney MA, Noll E, Black PM, Loeffler JS, Muzikansky A, Dyson NJ (2001) Prognostic and pathologic significance of quantitative protein expression profiling in human gliomas. Clin Cancer Res 7:2387-2395 (Pubitemid 32751640)
13. Shinojima N, Tada K, Shiraishi S, Kamiryo T, Kochi M, Nakamura H, Makino K, Saya H, Hirano H, Kuratsu J, Oka K, Ishimaru Y, Ushio Y (2003) Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme. Cancer Res 63:6962-6970 (Pubitemid 37322983)
14. Faillot T, Magdelenat H, Mady E, Stasiecki P, Fohanno D, Gropp P, Poisson M, Delattre JY (1996) A phase I study of an antiepidermal growth factor receptor monoclonal antibody for the treatment of malignant gliomas. Neurosurgery 39:478-483 (Pubitemid 26292020)
15. Baselga J (2002) Why the epidermal growth factor receptor? The rationale for cancer therapy. Oncologist 7(Suppl 4):2-8
16. Jendrossek V, Belka C, Bamberg M (2003) Novel chemotherapeutic agents for the treatment of glioblastoma multiforme. Expert Opin Investig Drugs 12:1899-1924 (Pubitemid 38016165)
17. Dancey J (2004) Epidermal growth factor receptor inhibitors in clinical development. Int J Radiat Oncol Biol Phys 58:1003-1007
18. Kapoor GS, O'Rourke DM (2003) Mitogenic signaling cascades in glial tumors. Neurosurgery 52:1425-1434 (discussion 1434-1425)
19. von Bossanyi P, Sallaba J, Dietzmann K, Warich-Kirches M, Kirches E (1998) Correlation of TGF-alpha and EGF-receptor expression with proliferative activity in human astrocytic gliomas. Pathol Res Pract 194:141-147 (Pubitemid 28192780)
20. Kordek R, Biernat W, Alwasiak J, Maculewicz R, Yanagihara R, Liberski PP (1995) p53 protein and epidermal growth factor receptor expression in human astrocytomas. J Neurooncol 26: 11-16
21. Orian JM, Vasilopoulos K, Yoshida S, Kaye AH, Chow CW, Gonzales MF (1992) Overexpression of multiple oncogenes related to histological grade of astrocytic glioma. Br J Cancer 66:106-112
22. Hwang SL, Chai CY, Lin HJ, Howng SL (1997) Expression of epidermal growth factor receptors and c-erbB-2 proteins in human astrocytic tumors. Kaohsiung J Med Sci 13:417-424
23. Mottolese M, Natali PG, Coli A, Bigotti G, Benevolo M, Cione A, Raus L, Carapella CM (1998) Comparative analysis of proliferating cell nuclear antigen and epidermal growth factor receptor expression in glial tumours: correlation with histological grading. Anticancer Res 18:1951-1956 (Pubitemid 28344854)
24. Kleihues P, Davis RL, Ohgaki H, Burger PC, Westphal MM, Cavenee WK (2000) Diffuse astrocytoma. In: Kleihues P, Cavenee WK (eds) World Health Organization classification of tumours. Pathology and Genetics of Tumours of the Nervous system. IARC Press, Lyon, pp 22-26
25. Reifenberger J, Reifenberger G, Ichimura K, Schmidt EE, Wechsler W, Collins VP (1996) Epidermal growth factor receptor expression in oligodendroglial tumors. Am J Pathol 149:29-35 (Pubitemid 26230975)
26. Broholm H, Bols B, Heegaard S, Braendstrup O (1999) Immunohistochemical investigation of p53 and EGFR expression of oligodendrogliomas. Clin Neuropathol 18:176-180 (Pubitemid 29318056)
27. Hoang-Xuan K, He J, Huguet S, Mokhtari K, Marie Y, Kujas M, Leuraud P, Capelle L, Delattre JY, Poirier J, Broet P, Sanson M (2001) Molecular heterogeneity of oligodendrogliomas suggests alternative pathways in tumor progression. Neurology 57: 1278-1281 (Pubitemid 32947388)
28. Daumas-Duport C, Varlet P, Tucker ML, Beuvon F, Cervera P, Chodkiewicz JP (1997) Oligodendrogliomas: part I: patterns of growth, histological diagnosis, clinical and imaging correlations: a study of 153 cases. J Neurooncol 34:37-59 (Pubitemid 27270251)
29. Cavenee WK, Furnari FB, Nagane M, Huang H-JS, Newcomb EW, Bigner DD, Weller M, Berens ME, Plate KH, Israel MA, Noble MD, Kleihues P (2000) Diffusely infiltrating astrocytomas. In: Kleihues P, Cavenee WK (eds) World Health Organization classification of tumours. Pathology and genetics of tumours of the nervous system. IARC Press, Lyon, pp 10-21
30. Yaziji H, Massarani-Wafai R, Gujrati M, Kuhns JG, Martin AW, Parker JCJ (1996) Role of p53 immunohistochemistry in differentiating reactive gliosis from malignant astrocytic lesions. Am J Surg Pathol 20:1086-1090 (Pubitemid 26276929)
31. Prayson RA, Agamanolis DP, Cohen ML, Estes ML, Kleinschmidt- DeMasters BK, Abdul-Karim F, McClure SP, Sebek BA, Vinay R (2000) Interobserver reproducibility among neuropathologists and surgical pathologists in fibrillary astrocytoma grading. J Neurol Sci 175:33-39 (Pubitemid 30227481)
32. Spaulding DC, Spaulding BO (2002) Epidermal growth factor receptor expression and measurement in solid tumors. Semin Oncol 29:45-54 (Pubitemid 35191046)
33. Werner MH, Nanney LB, Stoscheck CM, King LE (1988) Localization of immunoreactive epidermal growth factor receptors in human nervous system. J Histochem Cytochem 36:81-86 (Pubitemid 18023407)
34. Gomez-Pinilla F, Knauer DJ, Nieto-Sampedro M (1988) Epidermal growth factor receptor immunoreactivity in rat brain. Development and cellular localization. Brain Res 438:385-390
35. Damjanov I, Mildner B, Knowles BB (1986) Immunohistochemical localization of the epidermal growth factor receptor in normal human tissues. Lab Invest 55:588-592 (Pubitemid 17223207)
36. Junier MP (2000) What role(s) for TGFalpha in the central nervous system? Prog Neurobiol 62:443-473
37. Sabattini E, Bisgaard K, Ascani S, Poggi S, Piccioli M, Ceccarelli C, Pieri F, Fraternali-Orcioni G, Pileri SA (1998) The EnVision++ system: a new immunohistochemical method for diagnostics and research. Critical comparison with the APAAP, ChemMate, CSA, LABC, and SABC techniques. J Clin Pathol 51:506-511 (Pubitemid 28375029)